[1] Barker JN.The immunopathology of psoriasis.Baillieres Clin Rheumatol, 1994,8:429-438. [2] 蔡绥,孙国均,郑敏.银屑病患者皮损和非皮损部位粘附分子的免疫组化研究.中华皮肤科杂志,1998, 31:79-81. [3] Griffiths CE, Boffa MJ, Gallatin WM, et al.Elevated levels of circulating intercellular adhesion molecule-3(cICAM-3) in psoriasis.Acta Derm Venereol, 1996,76:2-5. [4] 蔡绥,郑敏,孙国均.钙泊三醇外用治疗可减少银屑病皮损中 ICAM-3阳性浸润细胞的表达.中华皮肤科杂志,1998, 31:360-362. [5] Caproni M, Palleschi GM, Falcos D, et al.Pharmacologic modulation by cetirizine of some adhesion molecules expression in psoriatic skin lesion.Int J Dermatol,1995,34:510-513. [6] Lisby S, Ralfkiaer E, Rothlein R, et al.Intercellular adhesion molecule-1(ICAM-1) expression correlated to inflammation.Br J Dermatol,1989,120:479-484. [7] Das PK, deBoer OJ, Visser A, et al.Differential expression of ICAM-1, E-selectin and VCAM-1 by endothelial cells in psoriasis and contact dermatitis.Acta Derm Venereol Suppl(Stockh), 1994,186:21-22. [8] Krasowska D, Pietrzak A, Lecewicz-Torun B.Serum level of sELAM-1 in psoriatic patients correlates with disease activity.J Eur Acad Dermatol Venereol,1999,12:140-142. |